Ftse Mib
34.731,31
0,60%
DAX
20.399,16
0,25%
S&P 500
6.084,19
0,82%
NASDAQ
20.034,89
1,77%
Bitcoin
100.934,86
-0,26%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Gyre Therapeutics Inc (GYRE) Gyre Therapeutics Inc (GYRE) Notizie

Gyre Therapeutics Inc

GYRE
10,02
-0,97 (-8,83%)
11 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
27/11/202422:25EDGAR2Form 8-K - Current report
27/11/202422:21EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
25/11/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
14/11/202422:39EDGAR2Form S-3 - Registration statement under Securities Act of..
13/11/202412:00GLOBEGyre Therapeutics Reports Third Quarter 2024 and..
22/10/202422:05GLOBEGyre Therapeutics Announces Last Patient Completed Pivotal..
01/10/202422:05GLOBEGyre Therapeutics to Present at 8th Annual H.C. Wainwright..
06/9/202414:31EDGAR2Form SC 13D - General Statement of Acquisition of Beneficial..
06/9/202414:15EDGAR2Form SC 13D - General Statement of Acquisition of Beneficial..
04/9/202422:05GLOBEGyre Therapeutics to Present at H.C. Wainwright 26th Annual..
13/8/202412:00GLOBEGyre Therapeutics Reports Second Quarter 2024 and..
09/8/202413:00GLOBEGyre Therapeutics to Present at Sidoti Virtual Investor..
08/8/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202422:05GLOBEGyre Therapeutics Announces Appointment of David M. Epstein,..
02/7/202422:05GLOBEGyre Therapeutics Announces China’s NMPA Approval of..
18/6/202422:05GLOBEGyre Therapeutics Announces Publication in Journal of..
17/6/202422:30EDGAR2Form 8-K - Current report
30/5/202422:06EDGAR2Form S-3 - Registration statement under Securities Act of..
30/5/202422:05EDGAR2Form 8-K - Current report
30/5/202422:05GLOBEGyre Pharmaceuticals Receives IND Approval from China’s NMPA..
30/5/202422:02EDGAR2Form S-3 - Registration statement under Securities Act of..
28/5/202422:05GLOBEGyre Therapeutics Announces Expected Addition to the Russell..
13/5/202422:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:10GLOBEGyre Therapeutics Reports First Quarter 2024 Financial..
09/5/202422:05EDGAR2Form 8-K - Current report
08/5/202414:00EDGAR2Form 8-K - Current report
26/3/202411:00GLOBEGyre Therapeutics Reports Full Year 2023 Financial Results..
21/3/202412:00GLOBEGyre Therapeutics Expands Board of Directors with..
15/12/202315:04PRNUSTotus Medicines Announces Appointment of Nassim Usman,..
Apertura: 11,00 Min: 10,03 Max: 11,0362
Chiusura: 10,99

La tua Cronologia

NASDAQ
GYRE
Gyre Therapeutics
USOTC
WYPH
Waypoint Biomedical (CE)
NYSE
ED
Consolidated Edison
AMEX
ARKC
ARK 21Shares Active On-C...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network